Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000525482) titled 'High Fibre Dietary Intervention in patients with Melanoma receiving Immune Checkpoint Inhibitors (HiFi-Mel)' on May 26.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Efficacy
Primary Sponsor: Peter MacCallum Cancer Centre
Condition:
Melanoma
Melanoma
Cancer - Malignant melanoma
Intervention:
This study involves a 9 week dietician-led dietary counselling intervention to escalate daily fibre intake to >30g per day, concurrent with a neoadjuvant immune therapy regimen for melanoma plann...